Biopharmaceutical MannKind, which has its headquarters in Westlake Village, is positioning itself as a med-tech platform. (Courtesy photo) MannKind shares skyrocketed as much as 26% on May 6 after the Westlake Village-based biotech company announced it has been developing a new treatment alongside United Therapeutics, just hours before it also released its results for the…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
